Skip to content

Population pharmacokinetic analysis of lidocaine in underweight patients

Population pharmacokinetic analysis of lidocaine in underweight patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090300
Enrollment
Unknown
Registered
2024-09-26
Start date
2024-09-27
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

underweight

Interventions

Sponsors

Department of Anesthesiology, Affiliated Hospital of Sichuan North Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? ASA class I-III, age 18-65 years. ? BMI <18.5 kg/m2 in underweight patients and between 18.5 kg/m2 -25 kg/m2 in normal weight patients. ? Not participating in other drug trials 2 weeks prior to the trial. ? No other factors affecting the metabolism of lidocaine. ? Able to read and understand the contents of the informed consent form and able to sign the informed consent form.

Exclusion criteria

Exclusion criteria: ? Allergic to lidocaine and narcotic drugs. ? Severe heart, brain and lung diseases. ? Severe hepatic and renal insufficiency impairment. ? Long-term use of cimetidine, beta-blockers and other drugs that affect the metabolism of lidocaine. ? Pregnant or lactating women. ? History of epilepsy.

Design outcomes

Primary

MeasureTime frame
Plasma lidocaine concentration;

Countries

China

Contacts

Public ContactTu Faping

Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College

tfpnc@163.com+86 138 0827 0833

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026